Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo

作者：Liang Chen, Yan Li, Yan Li, Miao Bai, Yanxin Huang, Hang Yang, Lei Liu, Shuyue Wang, Chunlei Yu, Zhenbo Song, Yongli Bao, Jingwen Yi, Luguo Sun, Yuxin Li, Yuxin Li · 发表于：Pharmacological Research · 年份：2020 · DOI：10.1016/j.phrs.2020.104657 · 被引用次数：59 · 研究领域：Diet, Metabolism, and Disease、Liver Disease Diagnosis and Treatment、Metabolism, Diabetes, and Cancer